Drägerwerk AG & Co. KGaA (DRWKF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Drägerwerk AG & Co. KGaA (DRWKF) with AI Score 50/100 (Hold). Drägerwerk AG & Co. KGaA is a global leader in medical and safety technology, providing solutions for emergency care, industrial safety, and gas detection. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Drägerwerk AG & Co. KGaA (DRWKF) Healthcare & Pipeline Overview
Drägerwerk AG & Co. KGaA, founded in 1889, is a global medical and safety technology provider, offering solutions from emergency and intensive care to personal protection and gas detection. With a presence in both medical and industrial sectors, the company serves diverse clients, including hospitals, fire departments, and mining operations, with a focus on innovation and comprehensive risk management.
Investment Thesis
Drägerwerk AG & Co. KGaA presents a compelling investment case due to its established position in the medical and safety technology sectors. The company's diverse product portfolio and global presence provide a stable revenue base, while its focus on innovation and comprehensive solutions drives long-term growth. With a profit margin of 3.5% and ROE of 8.2%, the company demonstrates financial stability. Key catalysts include increasing demand for advanced medical devices and safety equipment, driven by aging populations and stricter safety regulations. However, investors may want to evaluate potential risks such as currency fluctuations and competitive pressures. The company's beta of 0.69 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $2.13B reflects its significant presence in the medical and safety technology sectors.
- Gross Margin of 45.3% indicates strong pricing power and efficient cost management.
- Return on Equity (ROE) of 8.2% demonstrates the company's ability to generate profits from shareholders' investments.
- Debt-to-Equity Ratio of 24.93 indicates a conservative capital structure.
- Beta of 0.69 suggests lower volatility compared to the broader market, potentially offering stability during market downturns.
Competitors & Peers
Strengths
- Diversified product portfolio in medical and safety technology.
- Global presence with established distribution networks.
- Strong brand reputation for quality and reliability.
- Focus on innovation and comprehensive solutions.
Weaknesses
- Exposure to currency fluctuations.
- Dependence on regulatory approvals.
- Limited presence in emerging markets compared to some competitors.
- Relatively low profit margin compared to industry leaders.
Catalysts
- Ongoing: Increasing demand for medical devices due to aging populations and rising healthcare expenditures.
- Ongoing: Growing awareness of workplace safety and stricter regulations driving demand for safety equipment.
- Upcoming: Potential for new product launches in AI-powered diagnostics and remote patient monitoring.
- Ongoing: Expansion in emerging markets with growing healthcare and safety needs.
Risks
- Potential: Exposure to currency fluctuations affecting revenue and profitability.
- Potential: Changes in regulatory requirements and healthcare policies impacting product approvals and market access.
- Potential: Economic downturns affecting capital spending by hospitals and industrial clients.
- Ongoing: Intense competition from established players and new entrants in the medical and safety technology sectors.
- Potential: Supply chain disruptions and rising raw material costs affecting production and profitability.
Growth Opportunities
- Expansion in Emerging Markets: Drägerwerk AG & Co. KGaA can capitalize on the growing healthcare and safety markets in emerging economies. These regions often have less stringent regulations and lower labor costs, providing opportunities for increased market penetration and profitability. By tailoring its products and services to meet the specific needs of these markets, Drägerwerk can tap into a significant growth driver. The global medical device market is projected to reach $600 billion by 2028, offering a substantial opportunity for expansion.
- Development of Innovative Products: Investing in research and development to create innovative medical and safety technologies can drive future growth. Focusing on areas such as remote patient monitoring, AI-powered diagnostics, and advanced respiratory protection can differentiate Drägerwerk from its competitors and attract new customers. The market for AI in healthcare is expected to reach $34 billion by 2027, presenting a significant opportunity for Drägerwerk to leverage its expertise.
- Strategic Acquisitions: Pursuing strategic acquisitions of smaller companies with complementary technologies or market access can accelerate growth and expand Drägerwerk's product portfolio. Identifying companies with innovative solutions in niche markets can provide a competitive edge and enhance the company's overall value proposition. The medical device industry is highly fragmented, offering numerous acquisition opportunities for Drägerwerk.
- Enhanced Service Offerings: Expanding service offerings, such as maintenance, training, and consulting, can generate recurring revenue streams and strengthen customer relationships. Providing comprehensive support and solutions can differentiate Drägerwerk from its competitors and increase customer loyalty. The global healthcare services market is projected to reach $13 trillion by 2027, highlighting the potential for growth in this area.
- Strengthening Digital Presence: Enhancing its digital presence through e-commerce platforms, online marketing, and telemedicine solutions can improve customer reach and streamline operations. Investing in digital technologies can also enable Drägerwerk to collect and analyze data, providing valuable insights for product development and marketing strategies. The global telemedicine market is expected to reach $429 billion by 2029, presenting a significant opportunity for Drägerwerk to leverage its digital capabilities.
Opportunities
- Expansion in emerging markets with growing healthcare and safety needs.
- Development of innovative products leveraging AI and digital technologies.
- Strategic acquisitions of smaller companies with complementary technologies.
- Enhanced service offerings to generate recurring revenue streams.
Threats
- Intense competition from established players and new entrants.
- Changes in regulatory requirements and healthcare policies.
- Economic downturns affecting capital spending by hospitals and industrial clients.
- Supply chain disruptions and rising raw material costs.
Competitive Advantages
- Strong brand reputation for quality and reliability.
- Extensive product portfolio covering both medical and safety sectors.
- Global presence with established distribution networks.
- High switching costs for customers due to regulatory requirements and training.
About DRWKF
Drägerwerk AG & Co. KGaA, established in 1889 and headquartered in Lübeck, Germany, operates as a global leader in medical and safety technology. The company develops, produces, and markets a wide range of system solutions, devices, and services for the medical and safety sectors. In the medical division, Drägerwerk focuses on emergency medicine, perioperative care, intensive care, and perinatal medicine, offering products such as patient monitoring systems, anesthesia machines, medical ventilators, and neonatal incubators. For the safety division, Drägerwerk provides solutions for personal protection, gas measurement technology, and comprehensive risk management, serving industries like mining, fire departments, and disaster protection. These products include respiratory protection equipment, gas detectors, thermal imaging cameras, and safety training systems. Drägerwerk's comprehensive approach includes not only product development and manufacturing but also service offerings, training, and hospital planning and design services. The company operates as a subsidiary of Stefan Dräger GmbH, ensuring a long-term commitment to innovation and quality in both medical and safety technology.
What They Do
- Develops and produces medical devices for emergency medicine, perioperative care, intensive care, and perinatal medicine.
- Offers patient monitoring systems, anesthesia machines, and medical ventilators.
- Manufactures neonatal incubators, thermoregulation devices, and phototherapy lights.
- Provides surgical and examination lights, medical pendants, and infrastructure design.
- Offers products for personal protection, gas measurement technology, and risk management.
- Supplies respiratory protection equipment, gas detectors, and thermal imaging cameras.
- Provides safety training systems and workshop solutions.
Business Model
- Develops and manufactures medical and safety technology products.
- Sells products directly to hospitals, industrial clients, and public sector organizations.
- Provides after-sales services, maintenance, and training.
- Generates revenue through product sales and service contracts.
Industry Context
Drägerwerk AG & Co. KGaA operates within the medical devices and safety equipment industries, both of which are experiencing steady growth. The medical devices market is driven by factors such as an aging global population, increasing prevalence of chronic diseases, and technological advancements. The safety equipment market is fueled by stricter regulations, growing awareness of workplace safety, and increasing demand for personal protective equipment. Drägerwerk competes with other major players in these markets, leveraging its reputation for quality and innovation to maintain its market position.
Key Customers
- Hospitals and healthcare providers.
- Industrial companies in mining, chemical, and manufacturing sectors.
- Fire departments, police, and disaster protection agencies.
- Public sector organizations.
Financials
Chart & Info
Drägerwerk AG & Co. KGaA (DRWKF) stock price: Price data unavailable
Latest News
No recent news available for DRWKF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DRWKF.
Price Targets
Wall Street price target analysis for DRWKF.
MoonshotScore
What does this score mean?
The MoonshotScore rates DRWKF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
DRWKF OTC Market Information
The OTC Other tier, where Drägerwerk AG & Co. KGaA trades, represents the lowest of the OTC market tiers. Companies in this tier often have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies are not subject to stringent listing requirements, including minimum asset size, revenue, or shareholder equity. This lack of regulatory oversight increases the risk for investors due to the potential for fraud and manipulation.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in DRWKF.
- Lower liquidity can lead to price volatility and difficulty in executing trades.
- Potential for fraud and manipulation due to lack of regulatory oversight.
- Higher risk of delisting or trading suspension compared to major exchanges.
- OTC stocks may be subject to less scrutiny from analysts and institutional investors.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any regulatory actions or legal issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Drägerwerk AG & Co. KGaA has a long operating history, founded in 1889.
- The company operates as a subsidiary of Stefan Dräger GmbH, suggesting a level of financial backing and oversight.
- Drägerwerk AG & Co. KGaA has a global presence and serves a diverse range of customers in the medical and safety sectors.
DRWKF Healthcare Stock FAQ
What does Drägerwerk AG & Co. KGaA do?
Drägerwerk AG & Co. KGaA is a global leader in medical and safety technology, providing a wide range of products, systems, and services. In the medical field, they focus on emergency, perioperative, intensive, and perinatal care, offering solutions like patient monitoring systems, anesthesia machines, and ventilators. For safety, they provide personal protection equipment, gas detection technology, and comprehensive risk management for industries like mining and fire services. Their offerings also include training, services, and hospital planning, making them a comprehensive solution provider in both sectors.
What are the main revenue streams for Drägerwerk AG & Co. KGaA in the healthcare sector?
Drägerwerk AG & Co. KGaA generates revenue in the healthcare sector through the sale of medical devices and related services. Key revenue streams include patient monitoring systems, anesthesia machines, medical ventilators, neonatal incubators, and surgical lights. Additionally, the company generates revenue through service contracts, maintenance, training, and hospital planning services. These diverse revenue streams provide a stable and recurring income base for the company.
What are the main risks for DRWKF?
Drägerwerk AG & Co. KGaA faces several risks, including currency fluctuations due to its global operations, which can impact revenue and profitability. Changes in regulatory requirements and healthcare policies could affect product approvals and market access. Economic downturns may reduce capital spending by hospitals and industrial clients. Intense competition in the medical and safety technology sectors could pressure pricing and market share. Supply chain disruptions and rising raw material costs could also affect production and profitability.
What are the key factors to evaluate for DRWKF?
Drägerwerk AG & Co. KGaA (DRWKF) currently holds an AI score of 50/100, indicating moderate score. Key strength: Diversified product portfolio in medical and safety technology.. Primary risk to monitor: Potential: Exposure to currency fluctuations affecting revenue and profitability.. This is not financial advice.
How frequently does DRWKF data refresh on this page?
DRWKF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DRWKF's recent stock price performance?
Recent price movement in Drägerwerk AG & Co. KGaA (DRWKF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified product portfolio in medical and safety technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider DRWKF overvalued or undervalued right now?
Determining whether Drägerwerk AG & Co. KGaA (DRWKF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying DRWKF?
Before investing in Drägerwerk AG & Co. KGaA (DRWKF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on available information and may be subject to change.
- OTC market data may have limited accuracy and availability.